In this paper we show that the GLP-1R agonist liraglutide delays progression towards obesity and prandial hyperglycemia and efficiently enhances in vivo GSIS in a mouse model of GC-induced metabolic syndrome. This evidence concerns the gene GLP1R and obesity due to melanocortin 4 receptor deficiency.